Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Clinical trial NCT00905398 · TERMINATED

Trial details

NCT number: NCT00905398
Sponsor: Rony Schaffel
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Acute Lymphoblastic Leukemia

Start date: 2009-05-01
Primary completion: 2012-06-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.